UK BROKER RATINGS SUMMARY: UBS Upgrades AstraZeneca To Neutral Read More
AstraZeneca's Forxiga Approved For Use In Japan On Robust Test Results Read More
LONDON MARKET CLOSE: Muted Friday Unable To Dent Positive Week Read More
REPEAT: LONDON MARKET: Indivior Down 45% On GBP1 Billion Reckitt Claim Read More
LONDON MARKET MIDDAY: Indivior Drops On Reckiitt's GBP1 Billion Claim Read More
UPDATE: AstraZeneca Says Its Vaccine Needs "Additional Study" Read More
"Additional Study" Needed For AstraZeneca Vaccine Says CEO Read More
LONDON MARKET CLOSE: FTSE Trails Peers Amid Thanksgiving Profit Taking Read More
UPDATE: AstraZeneca-Oxford 90% Vaccine Score Only In Younger Age Group Read More
PRESS: Doubts Raised Over AstraZeneca-Oxford Vaccine Data - FT Read More
UPDATE: UK PM Johnson Warns It Will Take Months To Vaccinate All In Need Read More
LONDON MARKET CLOSE: FTSE Trails Peers As Vaccine Boost Wanes Read More
UK To Receive 19 Million AstraZeneca Vaccine Doses By Year End Read More
LONDON MARKET PRE-OPEN: AstraZeneca Covid Vaccine Up To 90% Effective Read More
Trials For AstraZeneca's Covid-19 Treatment Set To Begin In UK Read More
TOP NEWS: AstraZeneca Says New Dosing Of Imfinzi Approved In US Read More
LONDON MARKET MIDDAY: Vaccine Cheer Recedes As Lockdown Jitters Return Read More
UK TOP NEWS SUMMARY: Oxford-Astra Vaccine Encouraging In Older Adults Read More
LONDON MARKET OPEN: NY Restrictions And Japan Virus Alert Damp Spirits Read More
TOP NEWS: Oxford Vaccine Shows Strong Immune Response In Older Adults Read More
